Topic: Patents

Latest content

Patent suits decline in Dusseldorf and Mannheim, but Munich’s docket is on the rise

Germany is Europe’s biggest and most active litigation forum, but subtle differences in case law and proceedings mean that plaintiffs have important choices to make about where to file their suits

16 November 2021

Four things to watch as China’s first patent linkage litigation is filed

Beijing IP Court lawsuit launched by Japan’s Chugai Pharmaceutical will be inaugural test of the new system, and possible procedural issues are already appearing

16 November 2021

Semiconductors, FRAND, diversity and danger – Day Two of IPBC Global 2021

Highlights from the plenaries, breakouts and networking sessions as the world’s premier IP business event continues in Seattle

16 November 2021

Judge rejects latest attack on PTAB discretionary denials, but other challenges loom

The fierce battle over the NHK-Fintiv rule could become a key question for the Biden Administration’s USPTO director nominee

15 November 2021

Xperi highlights recent China deal as it seeks to "re-establish" its chip licensing business

Licence pact with Yangtze Memory heralds new applications for a technology that’s core to the company’s semiconductor holdings

15 November 2021

IPBC Global kicks off at a time when private equity money is pouring into the IP market

Delegates talk big ticket investments and speculate on Kathi Vidal’s USPTO Director confirmation hearing in the Senate

15 November 2021

A multi-million-dollar patent damages win for J&J in China is good news for foreign rights holders

US company’s subsidiary secures major award against a local infringer at the Supreme People’s Court

12 November 2021

New Huawei transaction with top US patent asserter revealed

Dozens of communications patents changing hands in latest monetisation move from Chinese telecoms giant

12 November 2021

MediaTek and NXP in patent clash at ITC amidst growing US chip shortage

Leading semiconductor companies both seek limited exclusion orders to halt imports at a time when supplies are tight

11 November 2021

Moderna on IP collision course with US government

The company is at loggerheads with National Institutes of Health over inventorship of crucial covid vaccine technology

11 November 2021

Unlock unlimited access to all IAM content